Examiner: GREEN, MALIA NICOLE

Tech Center 1600 • Art Units: 1643

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

16.7%

§102 Novelty

16.7%

§103 Obviousness

50.0%

§112 Clarity

App #	Title	Status	Assignee
18477140	METHODS FOR TREATING INACTIVE THYROID EYE DISEASE	Non-Final OA	Horizon Therapeutics Ireland DAC
18489983	CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES	Non-Final OA	iBio, Inc.
18484635	EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III ANTIBODIES	Non-Final OA	iBio, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.